Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan (Q33371015)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan |
scientific article |
Statements
1 reference
Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan (English)
1 reference
N Ziras
1 reference
A Potamianou
1 reference
I Varthalitis
1 reference
K Syrigos
1 reference
S Tsousis
1 reference
I Boukovinas
1 reference
E Tselepatiotis
1 reference
C Christofillakis
1 reference
V Georgoulias
1 reference
25 April 2006
1 reference
1 reference
70
1 reference
106-114
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference